NMS · Biotechnology

CGON (CGON) Stock

$72.17 -1.84% NMS: CGON Healthcare

Valuation

MetricValue
Price$72.17
Market Cap$6.37B
P/E Ratio-26.72
P/B Ratio7.73
P/S Ratio1200.01
EPS (TTM)$0.00
52-Week High$75.24
52-Week Low$23.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-20.79%
ROA-14.42%
ROCE-25.37%
Gross Margin-4775.00%
Operating Margin-61.30%
Net Margin-36.83%
Debt/Equity0.01
Current Ratio31.30

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$0$0$1.0M$4.0M
Operating Profit$-13.0M$-35.0M$-55.0M$-115.0M$-191.0M
Net Profit$-13.0M$-35.0M$-49.0M$-88.0M$-161.0M
EPS$-0.28$-0.66$-1.02$-1.41$-2.08
Op Margin-121.7%-18453.4%-27180.9%-10067.3%-4722.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$59.0M$148.0M$199.0M$755.0M$792.0M
Total Liabilities$18.0M$23.0M$15.0M$21.0M$39.0M
Cash$54.0M$88.0M$8.0M$257.0M$32.0M
Borrowings$15.0M$16.0M$1.0M$0$7.0M

Latest News

CG Oncology Stock Gains 12% in Three Months: What's Driving It? Zacks · Jul 13, 2026 Big Insider Buying Puts These 2 Stocks on the Radar TipRanks · Jul 5, 2026 CG Oncology Insider Bought Shares Worth $24,814,454, According to a Recent SEC Filing MT Newswires · Jun 29, 2026 Non-muscle Invasive Bladder Cancer Market Dynamics to Shift During the Forecast Period (2026-2036) as Novel Targeted and Gene Therapies Enter Late-Stage Development | DelveInsight PR Newswire · Jun 23, 2026 CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead MarketBeat · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-30.0M$-46.0M$-79.0M$-132.0M
Investing Cash Flow$0$-55.0M$-121.0M$-301.0M$-246.0M
Financing Cash Flow$0$0$-1.0M$-1.0M$0
Net Cash Flow$2.0M$35.0M$-80.0M$249.0M$-225.0M
Free Cash Flow$-14.0M$-30.0M$-46.0M$-79.0M$-132.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.43
EV / EBITDA-24.86
FCF Yield-2.64%
Quick Ratio31.25
Interest Coverage—
Return 1Y166.62%
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.23%
Institutions Held109.81%
Institutions Float Held110.07%
Institutional HolderSharesReport Date
RTW Investments LP6,984,8082026-03-31
T. Rowe Price Investment Management, Inc.6,720,3892026-03-31
Decheng Capital LLC6,371,6692026-03-31
Wellington Management Group, LLP5,371,2322026-03-31
Blackrock Inc.5,064,1802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPGAscentage Pharma Group International $20.18 +4.89% -9.87 $1.88B 0.00%
APGE $134.19 +0.06% -16.89 $8.30B 0.00%
CELC $92.49 +5.44% -91.68 $4.51B 0.00%
CNTACentessa Pharmaceuticals plc $40.50 +0.00% -22.75 $6.27B 0.00%
IRON $73.86 -1.01% -9.08 $2.82B 0.00%

About CGON

CGON is led by CEO Arthur Kuan, employs 142 people, headquartered in Dallas, US, publicly traded since 2024.

CGON stock trades at $72.17 with a market capitalization of $6.37B. The stock is valued at a price-to-earnings (P/E) ratio of -26.72, price-to-book of 7.73, price-to-sales of 1200.01. Over the past 52 weeks the stock has ranged between $23.32 and $75.24, and currently trades 4.1% below its 52-week high.

On profitability, CGON generates a return on equity (ROE) of -20.79%, return on capital employed of -25.37%, an operating margin of -61.30%, a net profit margin of -36.83%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides